Cancer Family
Malignant Breast Neoplasm
CI-CAN-00000227Explore in graph →
Top-level2,628 active trials43 approved drugs310 evidence items
- NCIt
- C9335
- ICD-10
- C50
- DOID
- 1612
- Other
- 2 more codes
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000227Explore in graph →
Clinical trials
12,359 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,368)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04137653 | Treatment of Triple-negative Breast Cancer With Albumin-bound Paclitaxel as Neoadjuvant Therapy: a Prospective RCT | recruiting | Phase 3 | 1,498 | Shengjing HospitalOTHER | 1 | Jul 20, 2021 | clinicaltrials |
| NCT04476485 | Sj-subway, a Predictor for the Recurrence of High-risk Hormone Receptor-positive Breast That is Sensitive to Extended Endocrine Therapy | recruiting | — | 1,000 | Shengjing HospitalOTHER | 1 | Jul 20, 2021 | clinicaltrials |
| NCT03787056 | Predictive Value of Progastrin Titer at Diagnosis and of Progastrin Kinetics During Treatment in Cancer Patients(ONCOPRO) | recruiting | N/A | 410 | Hospices Civils de LyonOTHER | 1 | Jul 16, 2021 | clinicaltrials |
| NCT04960839 | Prophylactic Irradiation to the Contralateral Breast for BCAs Patients(PICB) | recruiting | N/A | 323 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 2 | Jul 14, 2021 | clinicaltrials |
| NCT04947280 | Single Arm Phase II Study of Fractionated Stereotatic Radiation Therapy (FSRT) for Bone Metastases in Breast Cancer | recruiting | Phase 1 / Phase 2 | 120 | Fudan UniversityOTHER | 1 | Jul 1, 2021 | clinicaltrials |
| NCT04878666 | Prospective Assessment of Quality of Life in Patients With Locally Recurrent Breast Cancer and Hyperthermic Radiotherapy(UKT HT03_1) | recruiting | — | 20 | University Hospital TuebingenOTHER | 1 | May 7, 2021 | clinicaltrials |
| NCT04019678 | Breast Cancer: Axillary Conservation After Neoadjuvant Chemotherapy in Micro Metastatic Sentinel Lymph Nodes.(NEONOD2) | recruiting | N/A | 850 | Istituto Clinico HumanitasOTHER | 1 | Apr 19, 2021 | clinicaltrials |
| NCT04669873 | Accelerated Partial Breast Irradiation Versus Standard or Hypofractionated Whole-Breast Irradiation, in Early Breast Cancer, After Breast-conserving Surgery(LAPIDARY) | recruiting | N/A | 36 | Instituto Brasileiro de Controle do CancerOTHER | 1 | Mar 8, 2021 | clinicaltrials |
| NCT04736589 | Inetetamab Plus Rapamycin and Chemotherapy for HER2+ Metastatic Breast Cancer With Abnormal Activation of PAM Pathway | not yet recruiting | Phase 3 | 270 | Peking Union Medical CollegeOTHER | 1 | Feb 3, 2021 | clinicaltrials |
| NCT04665882 | Nomogram to Predict Breast Cancer Related Lymphedema | recruiting | N/A | 600 | Wuhan UniversityOTHER | 1 | Dec 16, 2020 | clinicaltrials |
| NCT04646759 | Fulvestrant or Capecitabine Combined With Pyrotinib in HR+/HER2+ Metastatic Breast Cancer | recruiting | Phase 3 | 516 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | Nov 30, 2020 | clinicaltrials |
| NCT03591276 | Phase 1b Study of Pegylated Liposomal Doxorubicin and Pembrolizumab in Endocrine-resistant Breast Cancer(KEYDOX) | recruiting | Phase 1 / Phase 2 | 15 | Shaare Zedek Medical CenterOTHER | 1 | Oct 23, 2020 | clinicaltrials |
| NCT02568839 | Neoadjuvant Response-guided Treatment of HER2 Positive Breast Cancer(PREDIX HER2) | active not recruiting | Phase 2 / Phase 3 | 202 | Thomas HatschekOTHER | 1 | Aug 13, 2020 | clinicaltrials |
| NCT04488614 | Prospective Breast Cancer Biobanking(PBCB) | enrolling by invitation | — | 1,200 | Helse Stavanger HFOTHER_GOV | 1 | Jul 30, 2020 | clinicaltrials |
| NCT04481763 | A Study of the Efficacy and Safety of Camrelizumab Plus Radiotherapy for Patients With Early Triple-Negative Breast | recruiting | Phase 1 / Phase 2 | 20 | Jiangxi Provincial Cancer HospitalOTHER | 1 | Jul 22, 2020 | clinicaltrials |
| NCT04481932 | Trastuzumab Combined With Pyrrolidine and Chemotherapy for Locally HER2 Positive Breast Cancer | recruiting | Phase 2 | 104 | Peking UniversityOTHER | 1 | Jul 22, 2020 | clinicaltrials |
| NCT04072653 | Sentinel Node Biopsy Vs Observation After Axillary PET(SOAPET) | recruiting | N/A | 1,528 | Fudan UniversityOTHER | 1 | Jul 13, 2020 | clinicaltrials |
| NCT02592083 | Neoadjuvant Response-guided Treatment of Slowly Proliferating Hormone Receptor Positive Tumors(PREDIX LumA) | active not recruiting | Phase 2 | 10 | Thomas HatschekOTHER | 1 | Jul 7, 2020 | clinicaltrials |
| NCT03667417 | Genetic Predisposition to Breast and Ovarian Cancer: Prospective Study of BRCAx Gene Mutation(GENEPSO) | recruiting | — | 5,000 | Institut Paoli-CalmettesOTHER | 1 | Jul 1, 2020 | clinicaltrials |
| NCT04437160 | Adjuvant Chemotherapy for Triple Negative Breast Cancer Patients With Residual Disease After Neoadjuvant Chemotherapy | recruiting | Phase 2 | 286 | Chinese Academy of Medical SciencesOTHER | 1 | Jun 18, 2020 | clinicaltrials |
| NCT04426136 | A Prospective Cohort Study Comparing Disparity in Surgical Procedure (Wide Local Excision Only vs Any Other Surgery Procedures) Among the Elderly Breast Cancer Patients | not yet recruiting | — | 300 | Peking Union Medical College HospitalOTHER | 1 | Jun 11, 2020 | clinicaltrials |
| NCT04158843 | Radical Local vs. Palliative Therapy for Breast Cancer Patientts With Ipsilateral Humerus or Sternum Oligometastasis(BOMB) | recruiting | N/A | 183 | xuexin heOTHER | 1 | May 12, 2020 | clinicaltrials |
| NCT04281641 | Markers to Evaluate the Efficacy of PH-based Regimen as a Neoadjuvant Therapy for Operable HER2 Positive Breast Cancer(PHC-BC) | recruiting | N/A | 94 | Fudan UniversityOTHER | 1 | May 4, 2020 | clinicaltrials |
| NCT04356235 | Examining and Comparing the Temporal Changes and Results of Cosmetic, Quality of Life and Patient Satisfaction Achieved With Immediate and Delayed-immediate Implant-based Breast Reconstruction Procedures and Contralateral Symmetrization Techniques | recruiting | — | 528 | National Institute of Oncology, HungaryOTHER | 1 | Apr 22, 2020 | clinicaltrials |
| NCT04349527 | Comparison of the Cosmetic Results, Quality of Life and Patient Satisfaction Achieved With Round-block and Retroglandular Oncoplastic Breast Conserving Surgeries | recruiting | — | 242 | National Institute of Oncology, HungaryOTHER | 1 | Apr 21, 2020 | clinicaltrials |
| NCT04301739 | to Evaluate Efficacy and Safety of HLX10 in Combination With Chemotherapy Versus Placebo in Combination With Chemotherapy as Neoadjuvant Therapy and HLX10 Versus Placebo as Adjuvant Therapy in Patients With Triple Negative Breast Cancer (TNBC) | not yet recruiting | Phase 3 | 522 | Shanghai Henlius BiotechINDUSTRY | 0 | Mar 12, 2020 | clinicaltrials |
| NCT02338310 | Trial of Perioperative Endocrine Therapy - Individualising Care(POETIC) | active not recruiting | Phase 3 | 4,486 | Institute of Cancer Research, United KingdomOTHER | 1 | Feb 17, 2020 | clinicaltrials |
| NCT04225858 | Avoiding Sentinel Lymph Node Biopsy in Breast Cancer Patients After Neoadjuvant Chemotherapy(ASICS) | not yet recruiting | N/A | 340 | The Netherlands Cancer InstituteOTHER | 0 | Jan 13, 2020 | clinicaltrials |
| NCT04172753 | Feasibility of Online MR-guided Radiotherapy on a 1.5T MR-Linac | recruiting | N/A | 472 | University Hospital TuebingenOTHER | 1 | Nov 21, 2019 | clinicaltrials |
| NCT04158856 | Adjuvant Dual Anti-HER2 Therapy in Patients With Small, Node-negative, HER2-positive Breast Cancer(SHERO) | not yet recruiting | Phase 2 | 60 | xuexin heOTHER | 0 | Nov 12, 2019 | clinicaltrials |
| NCT04025164 | Hypofractionated Vs Conventional Fractionated Radiotherapy After Breast Conserving Surgery | recruiting | N/A | 4,052 | Fudan UniversityOTHER | 1 | Jul 18, 2019 | clinicaltrials |
| NCT03880097 | Enabling the Study of Metabolism in Breast Cancer Through Collection of Fresh-tissue Biopsies(ENSEMBLE) | not yet recruiting | — | 240 | University College, LondonOTHER | 0 | Mar 19, 2019 | clinicaltrials |
| NCT03561740 | A Study of the Addition of Metronomic Capecitabine to Standard Adjuvant Therapy in High Risk HER2+ BC paTients(SMART) | recruiting | Phase 3 | 794 | Sun Yat-sen UniversityOTHER | 1 | Jul 26, 2018 | clinicaltrials |
| NCT03392233 | Stereotactic Body Radiation Therapy for Spinal Metastases in Favorite Tumors | recruiting | Phase 2 | 100 | RenJi HospitalOTHER | 1 | Jan 5, 2018 | clinicaltrials |
| NCT02491697 | Immunotherapy Combined With Capecitabine Versus Capecitabine Monotherapy in Advanced Breast Cancer | active not recruiting | Phase 2 | 400 | The First People's Hospital of ChangzhouOTHER | 0 | Feb 23, 2016 | clinicaltrials |
| NCT01185132 | Intensity Modulated Radiotherapy (IMRT) vs. 3D-conformal Accelerated Partial Breast Irradiation (APBI) for Early Stage Breast Cancer After Lumpectomy(2009-APBI) | recruiting | Phase 3 | 660 | Rocky Mountain Cancer CentersOTHER | 1 | Jun 26, 2014 | clinicaltrials |
Data updated 22 days agoSource updated Jul 20, 2021source: clinicaltrials